Showing results (381-390 of 2,886) with videos related to
Sort By:
Pageof 289
Circulation|August 11, 2004
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromesKaeng W Lee, Gregory Y H Lip, Andrew D BlannArchives of Internal Medicine|September 15, 2004
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heartHoong Sern Lim, Robert J MacFadyen, Gregory Y H LipEuropean Journal of Clinical Investigation|October 5, 2022
Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillationRungroj Krittayaphong, Wiwat Kanjanarutjawiwat, Treechada Wisaratapong, et al.International Journal of Cardiology|February 2, 2016
Anticoagulant therapy after venous thromboembolism and 10-year mortalityTorben Bjerregaard Larsen, Gregory Y H Lip, Anders Gorst-RasmussenCurrent Pharmaceutical Design|September 2, 2014
Best practice for atrial fibrillation patient educationDeirdre A Lane, Rachel V Barker, Gregory Y H LipClinical Research in Cardiology : Official Journal of the German Cardiac Society|November 4, 2015
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trialMarco Proietti, Valeria Raparelli, Brian Olshansky, et al.International Journal of Cardiology|June 10, 2009
Obstructive sleep apnea and cardiovascular diseaseMehmood Butt, Girish Dwivedi, Omer Khair, et al.Chest|October 28, 2009
Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillationTimothy Watson, Anita Arya, Neil Sulke, et al.Annals of Medicine|July 12, 2008
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failureIrene Chung, Anirban Choudhury, Jeetesh Patel, et al.Plos One|June 24, 2014
Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisonsPaolo Verdecchia, Fabio Angeli, Gregory Y H Lip, et al.Pageof 289